Skip to main content
SpringerLink
Log in

Advanced MR Methods in Differential Diagnosis of Brain Tumors

  • Chapter
Brain Tumor Imaging

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

  • 2858 Accesses

Abstract

Conventional MRI may considerably improve the differential diagnosis of space-occupying brain lesions. However, the specificity for providing a definite diagnosis remains limited. Given the fact that final diagnosis should be based on histopathology and immunohistochemistry, imaging diagnosis seems to be of minor significance. However, some decisions must be met prior to surgical tissue sampling, e.g., the avoidance of steroids if CNS lymphoma is suspected or the definition of the target area for biopsy in inhomogeneous gliomas (see Chap. 2)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Andersen C, Haselgrove JC, Doenstrup S, Astrup J, Gyldensted C (1993) Resorption of peritumoural oedema in cerebral gliomas during dexamethasone treatment evaluated by NMR relaxation time imaging. Acta Neurochir (Wien) 122:218–224

    Article  CAS  Google Scholar 

  • Bähr O, Hattingen E, Rieger J, Steinbach JP (2011) Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma. Neuro Oncol 13:1020–1029

    Article  PubMed  PubMed Central  Google Scholar 

  • Bähr O, Harter PN, Weise LM, You SJ, Mittelbronn M, Ronellenfitsch MW, Rieger J, Steinbach JP, Hattingen E (2014) Sustained focal antitumor activity of bevacizumab in recurrent glioblastoma. Neurology 83:227–234

    Article  PubMed  Google Scholar 

  • Bastin ME, Sinha S, Whittle IR, Wardlaw JM (2002) Measurements of water diffusion and T1 values in peritumoural oedematous brain. Neuroreport 13:1335–1340

    Article  PubMed  Google Scholar 

  • Berghoff AS, Spanberger T, Ilhan-Mutlu A, Magerle M, Hutterer M, Woehrer A, Hackl M, Widhalm G, Christen T, Lemasson B, Pannetier N, Farion R, Remy C, Zaharchuk G, Barbier EL (2012) Is T2* enough to assess oxygenation? Quantitative blood oxygen level-dependent analysis in brain tumor. Radiology 262:495–502

    Article  Google Scholar 

  • Boyko OB, Burger PC, Shelburne JD, Ingram P (1992) Non-heme mechanisms for T1 shortening: pathologic, CT, and MR elucidation. AJNR Am J Neuroradiol 13:1439–1445

    PubMed  CAS  Google Scholar 

  • Cai K, Haris M, Singh A, Kogan F, Greenberg JH, Hariharan H, Detre JA, Reddy R (2012) Magnetic resonance imaging of glutamate. Nat Med 18:302–306

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Chan KW, McMahon MT, Kato Y, Liu G, Bulte JW, Bhujwalla ZM, Artemov D, van Zijl PC (2012) Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med 68:1764–1773

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Cheng HL, Stikov N, Ghugre NR, Wright GA (2012) Practical medical applications of quantitative MR relaxometry. J Magn Reson Imaging 36:805–824

    Article  PubMed  Google Scholar 

  • Damadian R (1971) Tumor detection by nuclear magnetic resonance. Science 171(3976):1151–1153

    Article  PubMed  CAS  Google Scholar 

  • Englund E, Brun A, Larsson EM, Györffy-Wagner Z, Persson B (1986) Tumours of the central nervous system. Proton magnetic resonance relaxation times T1 and T2 and histopathologic correlates. Acta Radiol Diagn (Stockh) 27:653–659

    CAS  Google Scholar 

  • Fatouros PP, Marmarou A, Kraft KA, Inao S, Schwarz FP (1991) In vivo brain water determination by T1 measurements: effect of total water content, hydration fraction, and field strength. Magn Reson Med 17:402–413

    Article  PubMed  CAS  Google Scholar 

  • Haacke EM, Xu Y, Cheng YC, Reichenbach JR (2004) Susceptibility weighted imaging (SWI). Magn Reson Med 52:612–618

    Article  PubMed  Google Scholar 

  • Harguindey S, Arranz JL, Wahl ML, Orive G, Reshkin SJ (2009) Proton transport inhibitors as potentially selective anticancer drugs. Anticancer Res 29:2127–2136. Review

    PubMed  CAS  Google Scholar 

  • Haris M, Cai K, Singh A, Hariharan H, Reddy R (2011) In vivo mapping of brain myo-inositol. Neuroimage 54:2079–2085

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Hasan KM, Walimuni IS, Abid H, Datta S, Wolinsky JS, Narayana PA (2012) Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS. J Neurol Sci 313:99–109

    Article  PubMed  PubMed Central  Google Scholar 

  • Hattingen E, Jurcoane A, Daneshvar K, Pilatus U, Mittelbronn M, Steinbach JP, Bähr O (2013) Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival. Neuro Oncol 15:1395–1404

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Hoehn-Berlage M, Bockhorst K (1994) Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues. Technol Health Care 2:247–254

    PubMed  CAS  Google Scholar 

  • Hoehn-Berlage M, Tolxdorff T, Bockhorst K, Okada Y, Ernestus RI (1992) In vivo NMR T2 relaxation of experimental brain tumors in the cat: a multiparameter tissue characterization. Magn Reson Imaging 10:935–947

    Article  PubMed  CAS  Google Scholar 

  • Hoskin PJ, Carnell DM, Taylor NJ, Smith RE, Stirling JJ, Daley FM, Saunders MI, Bentzen SM, Collins DJ, d’Arcy JA, Padhani AP (2007) Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations. Int J Radiat Oncol Biol Phys 68:1065–1071

    Article  PubMed  CAS  Google Scholar 

  • Jin T, Wang P, Zong X, Kim S-G (2012) Magnetic resonance imaging of the Amine–Proton EXchange (APEX) dependent contrast. Neuroimage 59:1218–1227

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Jones CK, Schlosser MJ, van Zijl PC, Pomper MG, Golay X, Zhou J (2006) Amide proton transfer imaging of human brain tumors at 3 T. Magn Reson Med 56:585–592

    Article  PubMed  Google Scholar 

  • Jurcoane A, Wagner M, Schmidt C, Mayer C, Gracien RM, Hirschmann M, Deichmann R, Volz S, Ziemann U, Hattingen E (2013) Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis. J Magn Reson Imaging 38:1454–1461

    Article  PubMed  Google Scholar 

  • Kim HS, Jahng GH, Ryu CW, Kim SY (2009) Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol 30:1574–1579

    Article  PubMed  CAS  Google Scholar 

  • Kimura T, Ohkubo M, Igarashi H, Kwee IL, Nakada T (2007) Increase in glutamate as a sensitive indicator of extracellular matrix integrity in peritumoral edema: a 3.0-tesla proton magnetic resonance spectroscopy study. J Neurosurg 106:609–613

    Article  PubMed  CAS  Google Scholar 

  • Larocque MP, Syme A, Yahya A, Wachowicz K, Allalunis-Turner J, Fallone BG (2009) Temporal and dose dependence of T2 and ADC at 9.4 T in a mouse model following single fraction radiation therapy. Med Phys 36:2948–2954

    Article  PubMed  Google Scholar 

  • Lin T, Autio J, Obata T, Kim SG (2011) Spin-locking versus chemical exchange saturation transfer MRI for investigating chemical exchange process between water and labile metabolite protons. Magn Reson Med 65:1448–1460

    Article  Google Scholar 

  • MacDonald HL, Bell BA, Smith MA, Kean DM, Tocher JL, Douglas RH, Miller JD, Best JJ (1986) Correlation of human NMR T1 values measured in vivo and brain water content. Br J Radiol 59:355–357

    Article  PubMed  CAS  Google Scholar 

  • Mittal S, Wu Z, Neelavalli J, Haacke EM (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 30:232–252

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Nasrallah FA, Pagès G, Kuchel PW, Golay X, Chuang KH (2013) Imaging brain deoxyglucose uptake and metabolism by glucoCEST MRI. J Cereb Blood Flow Metab 33:1270–1278

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Oh J, Cha S, Aiken AH, Han ET, Crane JC, Stainsby JA, Wright GA, Dillon WP, Nelson SJ (2005) Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging 21:701–708

    Article  PubMed  Google Scholar 

  • Park SM, Kim HS, Jahng GH, Ryu CW, Kim SY (2010) Combination of high-resolution susceptibility-weighted imaging and the apparent diffusion coefficient: added value to brain tumour imaging and clinical feasibility of non-contrast MRI at 3 T. Br J Radiol 83:466–475

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Peters S, Knöß N, Wodarg F, Cnyrim C, Jansen O (2012) Glioblastomas versus lymphomas: More diagnostic certainty by using susceptibility-weighted imaging (SWI). Fortschr Roentgenstr 184:713–718

    Article  CAS  Google Scholar 

  • Rieger J, Bähr O, Maurer GD, Hattingen E, Franz K, Brucker D, Walenta S, Kämmerer U, Coy JF, Weller M, Steinbach JP (2014) ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 44:1843–1852

    PubMed  CAS  PubMed Central  Google Scholar 

  • Rijpkema M, Schuuring J, van der Meulen Y, van der Graaf M, Bernsen H, Boerman R, van der Kogel A, Heerschap A (2003) Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging. NMR Biomed 16:12–18

    Article  PubMed  CAS  Google Scholar 

  • Saitta L, Heese O, Förster AF, Matschke J, Siemonsen S, Castellan L, Westphal M, Fiehler J, Goebell E (2011) Signal intensity in T2′ magnetic resonance imaging is related to brain glioma grade. Eur Radiol 21:1068–1076

    Article  PubMed  Google Scholar 

  • Schad LR, Blüml S, Zuna I (1993) MR tissue characterization of intracranial tumors by means of texture analysis. Magn Reson Imaging 11:889–896

    Article  PubMed  CAS  Google Scholar 

  • Sherry AD, Woods M (2008) Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu Rev Biomed Eng 10:391–411

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Sontheimer H (2008) A role for glutamate in growth and invasion of primary brain tumors. J Neurochem 105:287–295

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Tofts P (ed) Quantitative MRI of the brain: measuring changes caused by disease. John Wiley & Sons, Chichester, England in 2003. pp 272–298

    Google Scholar 

  • Togao O, Yoshiura T, Keupp J, Hiwatashi A, Yamashita K, Kikuchi K, Suzuki Y, Suzuki SO, Iwaki T, Hata N, Mizoguchi M, Yoshimoto K, Sagiyama K, Takahashi M, Honda H (2014) Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro Oncol 16:441–448

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Tóth V, Förschler A, Hirsch NM, den Hollander J, Kooijman H, Gempt J, Ringel F, Schlegel J, Zimmer C, Preibisch C (2013) MR-based hypoxia measures in human glioma. J Neurooncol 115:197–207

    Article  PubMed  Google Scholar 

  • van Zijl PC, Yadav NN (2011) Chemical exchange saturation transfer (CEST): what is in a name and what isn’t? Magn Reson Med 65:927–948

    Article  PubMed  PubMed Central  Google Scholar 

  • van Zijl PC, Zhou J, Mori N, Payen JF, Wilson D, Mori S (2003) Mechanism of magnetization transfer during on-resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids. Magn Reson Med 49:440–449

    Article  PubMed  Google Scholar 

  • van Zijl PC, Jones CK, Ren J, Malloy CR, Sherry AD (2007) MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci U S A 13(104):4359–4364

    Article  Google Scholar 

  • Ward KM, Balaban RS (2000) Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn Reson Med 44:799–802

    Article  PubMed  CAS  Google Scholar 

  • Ward KM, Aletras AH, Balaban RS (2000) A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 143:79–87

    Article  PubMed  CAS  Google Scholar 

  • Zhou J, van Zijl PC (2006) Chemical exchange saturation transfer imaging and spectroscopy. Prog Nucl Magn Reson Spectrosc 48:109–136

    Article  CAS  Google Scholar 

  • Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PC (2003a) Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med 50:1120–1126

    Article  PubMed  Google Scholar 

  • Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC (2003b) Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 9:1085–1090

    Article  PubMed  CAS  Google Scholar 

  • Zhou J, Blakeley JO, Hua J, Kim M, Laterra J, Pomper MG, van Zijl PC (2008) Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med 60:842–849

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhou J, Tryggestad E, Wen Z, Lal B, Zhou T, Grossman R, Wang S, Yan K, Fu DX, Ford E, Tyler B, Blakeley J, Laterra J, van Zijl PC (2011) Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 17:130–134

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuroradiology, Clinic of Rheinische, Friedrich-Wilhelms-University, Sigmund-Freud Straße 6, 53127, Bonn, Germany

    Elke Hattingen

  2. Brain Imaging Center (BIC), Goethe University Frankfurt, Schleusenweg 2-16, 60528, Frankfurt/Main, Germany

    Ulrike Nöth

  3. Neuroradiology, Goethe University Frankfurt, Schleusenweg 2-16, 60528, Frankfurt/Main, Germany

    Ulrich Pilatus

Authors
  1. Elke Hattingen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrike Nöth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulrich Pilatus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elke Hattingen .

Editor information

Editors and Affiliations

  1. Neuroradiology, Dept. of Radiol., University Hospital Bonn, Bonn, Germany

    Elke Hattingen

  2. Neuroradiology, Goethe University, Hospital Frankfurt, Frankfurt/Main, Germany

    Ulrich Pilatus

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hattingen, E., Nöth, U., Pilatus, U. (2014). Advanced MR Methods in Differential Diagnosis of Brain Tumors. In: Hattingen, E., Pilatus, U. (eds) Brain Tumor Imaging. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2014_1038

Download citation

  • DOI: https://doi.org/10.1007/174_2014_1038

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-45039-6

  • Online ISBN: 978-3-642-45040-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation